Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 9635

BillFederalHouseIn Committee
To amend the Federal Food, Drug, and Cosmetic Act to establish special rules to provide for continued review of human drug and device submissions during a lapse of appropriations, and for other purposes.
About This Bill
Committee
Latest Action · July 9, 2026
Referred to the House Committee on Energy and Commerce.
Introduced
July 9, 2026
Cosponsors (0)
None
View PDF ↗
SummaryFull TextCommentsAnnotations

Annotations on Text

0 annotations · Highlight text on the Summary or Full Text tab to add one
No annotations yet. Highlight a passage of the text to add one.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.